Current Report Filing (8-k)
September 22 2017 - 6:02AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
_________________________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (
Date of earliest event reported
)
September
22, 2017 (
September 19, 2017
)
ALR
TECHNOLOGIES INC.
(Exact
name of registrant as specified in its charter)
NEVADA
(State
or other jurisdiction of incorporation)
000-30414
(Commission
File No.)
7400
Beaufont Springs Drive
Suite
300
Richmond,
Virginia 23225
(Address
of principal executive offices) (Zip Code)
(804)
554-3500
(Registrant's
telephone number, including area code)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
[ ]
|
Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
ITEM
7.01 REGULATION
FD DISCLOSURE.
510(K)
Clearance
On
September 19, 2017 the Company announced that it has received 510(k) clearance from the United States Food and Drug Administration
for its insulin dose adjustment feature of the ALR Technologies Inc. Diabetes Managements System (also referred to as the “ALR
Health-e-Connect System”).
Deficient
Reporting Status
The
Company has received notice from the Securities and Exchange Commission (the “SEC”) that the Company is not in compliance
with its reporting requirements under the Securities Exchange Act (the “Act”). If the Company does not file all required
reports, the Company may be subject to an administrative proceeding to revoke its registration under the Act. The notice also
stated that the Company stock may be subject to a trading suspension by the SEC pursuant to the Act. At this time, the Company
does not have the resources to file all required reports to bring the Company into compliance, and to continue filing the required
reports to maintain compliance.
ITEM
9.01 EXHIBITS
AND FINANCIAL STATEMENTS.
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Dated
this 22st day of September 2017.
|
ALR TECHNOLOGIES INC.
|
|
|
|
|
BY:
|
SIDNEY
CHAN
|
|
|
Sidney Chan
|
|
|
Chief Executive Officer and Chairman of the
Board of Directors
|